Pácha J, Miksík I
Institute of Physiology, Czech Academy of Sciences, Prague, Czech Republic.
J Endocrinol. 1996 Mar;148(3):561-6. doi: 10.1677/joe.0.1480561.
The enzyme 11 beta-hydroxysteroid dehydrogenase (11 beta-OHSD) prevents the binding of corticosterone to mineralocorticoid receptors by reversible conversion of biologically active corticosterone to inactive 11-dehydrocorticosterone. To clarify the relationship between high plasma concentrations of corticosterone during weaning and high activity of intestinal transport pathways that are induced by aldosterone in immature intestine, we have studied the distribution, developmental pattern and regulation of 11 beta-OHSD in intestinal segments that possess mineralocorticoid target epithelium. Dehydrogenase activity was already high in the caecum, and the proximal and distal colon on the second postnatal day and altered little until adulthood. In contrast, the activity in the ileum was low during the first two weeks of life, rose more than 5-fold in the next 20 days to attain a peak in 30-day-old rats, and thereafter declined to the values of adult animals. There was no significant reductase activity (conversion of 11-dehydrocorticosterone to corticosterone) in any intestinal segment of young and adult rats. The regulation of intestinal 11 beta-OHSD by corticosteroids and thyroid hormones was studied in the ileum and distal colon. In weanling rats, adrenalectomy or a high-salt diet decreased 11 beta-OHSD activities in both intestinal segments whereas dexamethasone administration prevented this decline in adrenalectomized rats and administration of deoxycorticosterone acetate led to a significant increase of intestinal 11 beta-OHSD activities in rats kept on a high-salt diet. Dexamethasone administration to intact adult rats also stimulated 11 beta-OHSD activity in the ileum and distal colon. The changes in thyroid status of weanling rats did not change the 11 beta-OHSD activities. We conclude that (1) the developmental patterns of 11 beta-OHSD activity in the small and large intestine are not identical and this discrepancy may facilitate the maturation effect of glucocorticoids in the small intestine and the stimulatory effect of aldosterone in the large intestine and (2) corticosteroids but not thyroid hormones can modulate 11 beta-OHSD activity in the developing intestine.
11β-羟类固醇脱氢酶(11β-OHSD)可通过将具有生物活性的皮质酮可逆性转化为无活性的11-脱氢皮质酮,来阻止皮质酮与盐皮质激素受体结合。为阐明断奶期间血浆皮质酮浓度升高与未成熟肠道中醛固酮诱导的肠道转运途径高活性之间的关系,我们研究了具有盐皮质激素靶上皮的肠段中11β-OHSD的分布、发育模式及其调节。出生后第二天,盲肠以及近端和远端结肠中的脱氢酶活性就已经很高,直到成年都变化不大。相比之下,回肠中的活性在出生后的前两周较低,在接下来的20天内上升了5倍多,在30日龄大鼠中达到峰值,此后又降至成年动物的水平。在幼年和成年大鼠的任何肠段中均未检测到明显的还原酶活性(将11-脱氢皮质酮转化为皮质酮)。我们在回肠和远端结肠中研究了皮质类固醇和甲状腺激素对肠道11β-OHSD的调节作用。在断奶大鼠中,肾上腺切除术或高盐饮食可降低两个肠段中的11β-OHSD活性,而给予地塞米松可防止肾上腺切除大鼠出现这种活性下降,给予醋酸脱氧皮质酮可使高盐饮食大鼠的肠道11β-OHSD活性显著增加。对成年未切除肾上腺的大鼠给予地塞米松也可刺激回肠和远端结肠中的11β-OHSD活性。断奶大鼠甲状腺状态的变化并未改变11β-OHSD活性。我们得出结论:(1)小肠和大肠中11β-OHSD活性的发育模式并不相同,这种差异可能有助于糖皮质激素在小肠中的成熟作用以及醛固酮在大肠中的刺激作用;(2)皮质类固醇而非甲状腺激素可调节发育中肠道的11β-OHSD活性。